Enhancement of insulin secretion in adult onset diabetics by methysergide maleate: evidence for an endogenous biogenic monoamine mechanism as a factor in the impaired insulin secretion in diabetes mellitus.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D001786:Blood Glucose / Q000032:analysis; D002395:Catecholamines / Q000494:pharmacology*; D003920:Diabetes Mellitus / Q000097:blood / Q000378:metabolism* / Q000652:urine; D004298:Dopamine / Q000652:urine; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D007328:Insulin / Q000097:blood*; D007329:Insulin Antagonists; D008298:Maleates / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology*; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine; D010919:Placebos; D012701:Serotonin / Q000494:pharmacology* / Q000652:urine; D013268:Stimulation, Chemical; D014642:Vanilmandelic Acid / Q000652:urine
D015065:17-Hydroxycorticosteroids; D001786:Blood Glucose; D002395:Catecholamines; D007328:Insulin; D007329:Insulin Antagonists; D008298:Maleates; D010919:Placebos; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D014642:Vanilmandelic Acid; D004298:Dopamine; D009638:Norepinephrine; D008784:Methysergide